PHIA Koninklijke Philips N.V.

Hoag selects Philips to enhance and unify patient monitoring, elevating care across Orange County, USA

Hoag selects Philips to enhance and unify patient monitoring, elevating care across Orange County, USA

October 30, 2025

10-year collaboration aims to connect scalable monitoring technology that streamlines workflows, supporting patient safety and the patient and clinician experience



Amsterdam, the Netherlands and Newport Beach, Calif., USA
– (NYSE: PHG, AEX: PHIA), a global leader in health technology, and , Orange County, California’s highest-ranked hospital, today announced a landmark 10-year strategic collaboration. The initiative will standardize and modernize patient monitoring across Hoag’s two acute care hospitals, including its expanded Sun Family Campus in Irvine, which in mid-2026 will add 155 inpatient beds. The solution, which delivers continuous monitoring, supports early intervention, patient-centered care and enables informed decision-making across hospital environments.



Hoag will adopt Philips’ Enterprise Monitoring as a Service (EMaaS) model and implement the company’s latest IntelliVue  bedside and transport patient monitors across its network. This will create a unified, patient-centered monitoring environment that supports clinical efficiency, data continuity and patient safety. The Philips Patient Information Center () central patient monitor system serves as the foundation of this ecosystem, integrating patient monitoring data, clinical decision support tools, early warning scores and advanced analytics to enable clinicians to make informed decisions for the right patient at the right time. Hoag selected Philips’ EMaaS model to ensure continuous access to the innovations with financial predictability.



“Our partnership with Philips represents a shared commitment to advancing healthcare through collaboration, trust and innovation,” said Rick Martin, Hoag Senior Vice President and Chief Nursing Officer. “By creating a seamless monitoring environment that travels with the patient, we’re enhancing both the quality and comfort of care. Clinicians gain continuous insights wherever the patient is, which reduces disruptions, improves safety and ensures a more personalized experience. It’s another way Hoag is bringing world-class, accessible care to our community right here in Orange County.”



The combination of the Philips MX750 and X3 creates a powerful, software-driven monitoring solution that lets clinicians instantly adjust monitoring levels, flexibly transforming any bed to meet a patient’s changing acuity care needs while supporting rapid response and continuity of care. Designed to be scalable, secure and interoperable, Philips’ systems integrate with Hoag’s electronic health record (EHR) platform, supporting efficient and coordinated patient care.



“This collaboration is a transformative milestone in our journey to designing care that truly revolves around the needs of both patients and clinicians,” said Julia Strandberg, Chief Business Leader, Connected Care, Philips. “By deploying integrated monitoring solutions across Hoag’s network that flex to patient acuity and care setting, we’re enabling a smarter, more responsive care environment – one that supports clinical excellence, reduces complexity and delivers insights where and when they matter most. Together, we’re building the infrastructure for care that’s connected, scalable and ready for the future.”

Contact:

Mark Groves

Philips External Relations

Tel:

Email:



Avi Dines

Philips North America

Tel:

Email:

About Hoag

Hoag is a nonprofit, regional healthcare delivery system in Orange County, California. Delivering world-class, comprehensive, personalized care, Hoag consists of 1,800 top physicians, 18 urgent care facilities, 13 health & wellness centers, and two award-winning hospitals. Hoag offers a comprehensive blend of healthcare services that includes seven institutes providing specialized services in the following areas: cancer, digestive health, heart and vascular, neurosciences, spine, women’s health, and orthopedics through Hoag’s affiliate, Hoag Orthopedic Institute, which consists of an orthopedic hospital and five ambulatory surgical centers. Hoag is the highest ranked hospital in Orange County by U.S. News & World Report and the only OC hospital ranked in the Top 10 in California, as well as a designated Magnet® with Distinction hospital by the American Nurses Credentialing Center (ANCC). For more information, visit hoag.org.

About Royal Philips

Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health technology company focused on improving people’s health and well-being through meaningful innovation. Philips’ patient- and people-centric innovation leverages advanced technology and deep clinical and consumer insights to deliver personal health solutions for consumers and professional health solutions for healthcare providers and their patients in the hospital and the home.



Headquartered in the Netherlands, the company is a leader in diagnostic imaging, ultrasound, image-guided therapy, monitoring and enterprise informatics, as well as in personal health. Philips generated 2024 sales of EUR 18 billion and employs approximately 67,300 employees with sales and services in more than 100 countries. News about Philips can be found at .









The opinions and clinical experiences presented herein are specific to the featured topic(s) and are not linked to any specific patient and are for information purposes only. The medical experience(s) derived from specified topic(s) may not be predictive of all patients. Individual results may vary depending on a variety of patient-specific attributes and related factors. Nothing in this news announcement is intended to provide specific medical advice or to take the place of written law or regulations.

Attachments



EN
30/10/2025

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Koninklijke Philips N.V.

Livio Luyten ... (+4)
  • Livio Luyten
  • Michiel Declercq
  • Thibault Leneeuw
  • Wim Hoste
Michiel Declercq
  • Michiel Declercq

Philips Ready to Start from a Clean Sheet

Running up to the CMD on 10 February, we initiate coverage on Philips with an Accumulate rating and a €27.5 TP. While we see potential for the company to positively surprise with its 2028 margin ambitions, investors will likely focus on the phasing, as 2026 margins will still be held back by tariff normalization. Nevertheless, with the majority of Respironics-related uncertainty now behind us, we believe Philips has room to increase shareholder returns and potentially announce a new share buybac...

 PRESS RELEASE

Philips named a Clarivate Top 100 Global Innovator for the 13th consec...

Philips named a Clarivate Top 100 Global Innovator for the 13th consecutive year January 21, 2026 Highest-ranking medical technology company recognized in the Clarivate Top 100 Global Innovators list for 2026Innovations for healthcare professionals and consumers that support better care delivery and improve people’s health and well-beingIndustry-leading commitment to R&D, with over EUR 1.7 billion invested annually, equivalent to approximately 9% of sales Amsterdam, the Netherlands – (NYSE: PHG, AEX: PHIA), a global leader in health technology, has been named a for the 13th consecutive ...

 PRESS RELEASE

Philips agrees to acquire SpectraWAVE Inc., advancing next-generation ...

Philips agrees to acquire SpectraWAVE Inc., advancing next-generation coronary intravascular imaging and physiological assessment with AI December 15, 2025 Acquisition of SpectraWAVE’s next-generation technologies including HyperVueTM Imaging System with Enhanced Vascular Imaging for comprehensive, rapid, and AI-supported imaging inside the coronary arteries, and X1TM-FFR, an AI-enabled angio-based FFR technology that delivers rapid, accurate coronary physiology assessment from a single angiogram [1] SpectraWAVE’s technologies have the potential to significantly increase adoption of corona...

 PRESS RELEASE

Philips reiterates timing of 2026 outlook

Philips reiterates timing of 2026 outlook December 4, 2025 Amsterdam, the Netherlands – (NYSE: PHG, AEX: PHIA), a global leader in health technology, today reaffirmed that its 2026 outlook will be issued as planned on February 10, in line with the company’s previously communicated schedule. As previously guided, the company expects continued performance improvement with sequential comparable sales growth, expanded margins (despite tariff headwinds) and strong cashflow. The company continues to expect comparative sales growth to accelerate sequentially in 2026 towards mid-single-digit gro...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch